BNP Paribas Financial Markets

BNP Paribas Financial Markets Portfolio holdings

AUM $129B
1-Year Return 16.6%
 

BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.

This Quarter Return
-1.46%
1 Year Return
+16.6%
3 Year Return
+55.5%
5 Year Return
+79.05%
10 Year Return
+178.41%
AUM
$131B
AUM Growth
+$1.63B
Cap. Flow
+$4.8B
Cap. Flow %
3.67%
Top 10 Hldgs %
18.56%
Holding
4,730
New
154
Increased
1,743
Reduced
2,216
Closed
168

Sector Composition

1 Technology 25.21%
2 Financials 10.94%
3 Healthcare 10.54%
4 Consumer Discretionary 10.46%
5 Industrials 7.19%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
CTMX icon
4326
CytomX Therapeutics
CTMX
$330M
$11 ﹤0.01%
17
-61
-78% -$39
BIVI icon
4327
BioVie
BIVI
$14.1M
$10 ﹤0.01%
1
ALBT icon
4328
Avalon GloboCare
ALBT
$10.7M
$10 ﹤0.01%
2
CXAI icon
4329
CXApp
CXAI
$17.9M
$9 ﹤0.01%
10
SPRO icon
4330
Spero Therapeutics
SPRO
$107M
$9 ﹤0.01%
12
TCRT icon
4331
Alaunos Therapeutics
TCRT
$5.1M
$9 ﹤0.01%
6
-337
-98% -$506
IBIO icon
4332
iBio
IBIO
$18.3M
$8 ﹤0.01%
2
ICAD
4333
DELISTED
iCAD Inc
ICAD
$8 ﹤0.01%
4
MBIO icon
4334
Mustang Bio
MBIO
$11.4M
$8 ﹤0.01%
6
-1
-14% -$1
OCEA
4335
DELISTED
Ocean Biomedical, Inc. Common Stock
OCEA
$8 ﹤0.01%
143
IMUX icon
4336
Immunic
IMUX
$78.4M
$7 ﹤0.01%
6
MREO
4337
Mereo BioPharma
MREO
$294M
$7 ﹤0.01%
3
XXII
4338
22nd Century Group
XXII
$6.81M
0
-$27
HOTH icon
4339
Hoth Therapeutics
HOTH
$21.2M
$6 ﹤0.01%
+6
New +$6
NEXA icon
4340
Nexa Resources
NEXA
$657M
$6 ﹤0.01%
1
TOI icon
4341
The Oncology Institute
TOI
$285M
$6 ﹤0.01%
5
WATT icon
4342
Energous
WATT
$11.3M
$6 ﹤0.01%
1
MTVA
4343
MetaVia Inc. Common Stock
MTVA
$16.8M
$6 ﹤0.01%
4
AQB icon
4344
AquaBounty Technologies
AQB
$4.42M
$5 ﹤0.01%
7
FFAI
4345
Faraday Future Intelligent Electric Inc. Common Stock
FFAI
$253M
$5 ﹤0.01%
4
CGEN icon
4346
Compugen
CGEN
$125M
$4 ﹤0.01%
3
DOMH icon
4347
Dominari Holdings
DOMH
$102M
$4 ﹤0.01%
+1
New +$4
GSM icon
4348
FerroAtlántica
GSM
$773M
$4 ﹤0.01%
1
CTSO icon
4349
Cytosorbents Corp
CTSO
$58.9M
$3 ﹤0.01%
3
NNDM
4350
Nano Dimension
NNDM
$309M
$3 ﹤0.01%
2
+1
+100% +$2